A survey of 20-year-old Japanese women: how is their intention to undergo cervical cancer screening associated with their childhood HPV vaccination status?
HPV vaccine
attitude
cervical cancer screening
survey
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
01 02 2021
01 02 2021
Historique:
pubmed:
31
7
2020
medline:
23
6
2021
entrez:
31
7
2020
Statut:
ppublish
Résumé
In Japan, two groups of women, HPV vaccinated and unvaccinated, are approaching age 20, when they should begin cervical cancer screening. To improve Japan's current poor cervical cancer screening rate, we need to know how these women are thinking about screening. We conducted an internet survey of 20-y-old women, exploring their understanding of HPV and cervical cancer screening. We then gave them leaflets with basic information about HPV and cervical cancer, stressing the importance of early detection by screening. We analyzed the leaflet's effects on their attitudes based on their vaccination status. Our study of 618 women found a significantly higher intention for engagement for cervical cancer screening in women HPV-vaccinated as teenagers (29% versus 17%). They were also more aware that: (1) HPV is transmitted by sexual intercourse (49.1% versus 39.2%); (2) the HPV vaccine prevents cervical cancer (49.0% to 34.0%); and (3) the appropriate cervical cancer screening interval is every 2 y (63.3% versus 56.2%). Women in both groups responded well to the leaflet, with significant improvements in intention to receive screening. However, 65%-67% were not swayed. HPV-vaccinated women were more knowledgeable about cervical cancer and had a greater intention to receive screening. Our educational leaflet was moderately effective in both groups for increasing intentions to screen, but the majority in both groups were still resistant to screening. Japan needs to develop more effective educational programs and tools to vigorously impart the importance of cervical cancer screening.
Identifiants
pubmed: 32730107
doi: 10.1080/21645515.2020.1788326
pmc: PMC7899660
doi:
Substances chimiques
Papillomavirus Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
434-442Références
Pain Res Manag. 2016;2016:3689352
pubmed: 27445608
BMC Res Notes. 2018 Aug 13;11(1):572
pubmed: 30103830
Br J Anaesth. 2016 Jul;117(1):95-102
pubmed: 27317708
Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2154-9
pubmed: 17119040
Vaccine. 2018 Aug 9;36(33):4979-4992
pubmed: 30037416
Lancet Public Health. 2019 Jan;4(1):e19-e27
pubmed: 30291040
PLoS One. 2016 May 20;11(5):e0155955
pubmed: 27203284
Eur J Cancer Care (Engl). 2020 Jan;29(1):e13181
pubmed: 31639253
BMJ. 2014 Oct 28;349:g6192
pubmed: 25352501
Int J Cancer. 2016 Jun 15;138(12):2867-74
pubmed: 26856527
J Obstet Gynaecol Res. 2015 Dec;41(12):1965-71
pubmed: 26420072
PLoS One. 2016 Nov 18;11(11):e0166713
pubmed: 27861611
J Clin Diagn Res. 2017 Mar;11(3):QC21-QC24
pubmed: 28511455
Infect Drug Resist. 2019 Jul 04;12:1951-1967
pubmed: 31308715
PLoS One. 2017 Sep 5;12(9):e0183924
pubmed: 28873092
BMC Public Health. 2016 Sep 23;16(1):1013
pubmed: 27663658
J Obstet Gynaecol Res. 2016 Dec;42(12):1802-1807
pubmed: 27641631
Int J Clin Oncol. 2016 Oct;21(5):962-968
pubmed: 26968588
Vaccine. 2017 Dec 15;35(50):6931-6933
pubmed: 29150210
J Med Internet Res. 2017 Oct 16;19(10):e344
pubmed: 29038096
J Epidemiol. 2018 Mar 5;28(3):156-160
pubmed: 29129894
Papillomavirus Res. 2016 Dec;2:122-127
pubmed: 29074171
Public Health. 2005 Oct;119(10):875-84
pubmed: 16054179